Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × Patient Navigation × 90 days × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Lung Neoplasms 3 Colorectal Neoplasms 3 Hematopoietic and Lymphatic System Neoplasm 2 Breast Neoplasms 2 Uterine Cervical Neoplasms 1 Overweight 1 Obesity 1 Neoplasms 1 HER2+ Metastatic Breast Cancer (MBC) 1 Diabetes Mellitus 1 Carcinoma, Intraductal, Noninfiltrating 1

Interventions

pembrolizumab 34 Cyclophosphamide 20 Bevacizumab 14 Standard of Care 12 Nivolumab 11 Carboplatin 11 Blood Specimen Collection 11 atezolizumab 10 Rituximab 9 Pemetrexed 9 Paclitaxel 9 Interviews as Topic 9 Doxorubicin 9 fludarabine 8 Prednisone 8 Fluorouracil 8 Dexamethasone 8 Surveys and Questionnaires 7 Radiotherapy 7 venetoclax 6 olaparib 6 Oxaliplatin 6 Leucovorin 6 Fulvestrant 6 Exercise 6 pertuzumab 5 durvalumab 5 Vincristine 5 Trastuzumab 5 Temozolomide 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04234646 2025-12-22

Patient Navigation 2.0

Northwestern University

Phase NA Active not recruiting

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡